NCT01928394 2024-12-27A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid TumorsBristol-Myers SquibbPhase 1/2 Completed1,163 enrolled 33 charts 1 FDA
NCT03264066 2021-05-11A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid TumorsHoffmann-La RochePhase 2 Completed87 enrolled 24 charts
NCT00467779 2016-08-26Study of Cobimetinib in Participants With Solid TumorsGenentech, Inc.Phase 1 Completed119 enrolled 63 charts